Phase I/II study of tecemotide cancer immunotherapy for Japanese patients with unresectable stage III non-small cell lung cancer (NSCLC).

被引:3
作者
Nokihara, Hiroshi
Katakami, Nobuyuki
Hida, Toyoaki
Imamura, Fumio
Sakai, Hiroshi
Atagi, Shinji
Nishio, Makoto
Helwig, Christoph
Achiwa, Hiroyuki
Tamura, Tomohide
机构
[1] Natl Canc Ctr, Tokyo, Japan
[2] Inst Biomed Res & Innovat, Kobe, Hyogo, Japan
[3] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan
[4] Osaka Med Ctr, Osaka, Japan
[5] Saitama Canc Ctr, Saitama, Japan
[6] Kinki Chuo Chest Med Ctr, Osaka, Japan
[7] Japanese Fdn Canc Res, Tokyo, Japan
[8] Merck KGaA, Darmstadt, Germany
[9] Merck Serono Co Ltd, Tokyo, Japan
[10] St Lukes Int Hosp, Tokyo, Japan
关键词
D O I
10.1200/jco.2015.33.15_suppl.3036
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3036
引用
收藏
页数:1
相关论文
共 50 条
[11]   A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC) [J].
Tredaniel, J. ;
Mornex, F. ;
Barillot, I. ;
Diaz, O. ;
Hennequin, C. ;
Le Pechoux, C. ;
Lavole, A. ;
Giraud, P. ;
Souquet, P. -J. ;
Teixeira, L. ;
Vaylet, F. ;
Zalcman, G. ;
Baudrin, L. ;
Morin, F. ;
Milleron, B. .
REVUE DES MALADIES RESPIRATOIRES, 2011, 28 (01) :51-57
[12]   Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses [J].
Mitchell, P. ;
Thatcher, N. ;
Socinski, M. A. ;
Wasilewska-Tesluk, E. ;
Horwood, K. ;
Szczesna, A. ;
Martin, C. ;
Ragulin, Y. ;
Zukin, M. ;
Helwig, C. ;
Falk, M. ;
Butts, C. ;
Shepherd, F. A. .
ANNALS OF ONCOLOGY, 2015, 26 (06) :1134-1142
[13]   RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC) [J].
De Ruysscher, D. .
LUNG CANCER, 2009, 64 :S21-S21
[14]   Radiation therapy of stage I and II non-small cell lung cancer (NSCLC) [J].
Zierhut, D ;
Bettscheider, C ;
Schubert, K ;
van Kampen, M ;
Wannenmacher, M .
LUNG CANCER, 2001, 34 :S39-S43
[15]   Chemoradiation in older patients with stage III non-small cell lung cancer (NSCLC) [J].
Ng, Dawn M. ;
Sun, Alex ;
Coate, Linda ;
Ma, Clement ;
Bezjak, Andrea ;
Brade, Anthony ;
Burkes, Ronald L. ;
Cho, John ;
Feld, Ronald ;
Liu, Geoff ;
Shepherd, Frances ;
Leighl, Natasha B. .
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) :S858-S858
[16]   Immunotherapy for non-small cell lung cancer (NSCLC) [J].
Frost, Nikolaj ;
Reck, Martin .
INNERE MEDIZIN, 2022, 63 (07) :709-716
[17]   Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study [J].
Higgins, Kristin A. ;
Pillai, Rathi N. ;
Chen, Zhengjia ;
Tian, Sibo ;
Zhang, Chao ;
Patel, Pretesh ;
Pakkala, Suchita ;
Shelton, Jay ;
Force, Seth D. ;
Fernandez, Felix G. ;
Steuer, Conor E. ;
Owonikoko, Taofeek K. ;
Ramalingam, Suresh S. ;
Bradley, Jeffrey D. ;
Curran, Walter J. .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :1687-1695
[18]   Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer [J].
Sekine, I ;
Noda, K ;
Oshita, F ;
Yamada, K ;
Tanaka, M ;
Yamashita, K ;
Nokihara, H ;
Yamamoto, N ;
Kunitoh, H ;
Ohe, Y ;
Tamura, T ;
Kodama, T ;
Sumi, M ;
Saijo, N .
CANCER SCIENCE, 2004, 95 (08) :691-695
[19]   TECEMOTIDE (L-BLP25) IN UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER IN THE PHASE III START STUDY: FURTHER ENDPOINT AND EXPLORATORY BIOMARKER RESULTS [J].
Mitchell, Paul L. ;
Butts, Charles A. ;
Socinski, Mark A. ;
Thatcher, Nicholas ;
Wickart-Johansson, Gun ;
Ellis, Peter M. ;
Gladkov, Oleg ;
Pereira, Jose R. ;
Eberhardt, Wilfried E. E. ;
Horwood, Keith ;
Szczesna, Aleksandra ;
Helwig, Christoph ;
Schroeder, Andreas ;
Shepherd, Frances A. .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 :S135-S136
[20]   Phase II study of dasatinib in non-small cell lung cancer (NSCLC) [J].
Johnson, F. M. ;
Tang, X. ;
Tran, H. ;
Saigal, B. ;
Erasmus, J. ;
Kurie, J. ;
Hwang, L. ;
Oh, Y. ;
Lippman, S. ;
Stewart, D. J. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)